AM
CLMT icon

Appaloosa Management’s Calumet Specialty Products CLMT Stock Holding History

Appaloosa Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-437,439
Closed -$15.9M – 67
2013
Q2 		$15.9M Buy
+437,439
New +$15.7M 0.23% 54

Other funds holding CLMT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EAM
Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
CA
Corrado Advisors Ramsey, New Jersey $192M AUM 20.53% 1-Year Est. Return

Appaloosa Management's CLMT Position: Q3 2013 in Review

Appaloosa Management sold out of Calumet Specialty Products (CLMT) in Q3 2013, closing a stake of 437,439 shares — an estimated $15.9M sold.

Appaloosa Management first reported a position in CLMT in Q2 2013 and held it in 1 quarter. The position peaked at $15.9M in Q2 2013. 114 funds tracked by Wall St. Rank hold CLMT as of Q3 2013.

  • Appaloosa Management reported no remaining Calumet Specialty Products position as of Q3 2013 after selling out during the quarter.
  • Appaloosa Management sold 437,439 Calumet Specialty Products shares in Q3 2013, an estimated $15.9M.
  • Appaloosa Management first reported a position in Calumet Specialty Products in Q2 2013 and held it in 1 quarter.
  • Appaloosa Management's Calumet Specialty Products position peaked at $15.9M in Q2 2013.
  • 114 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2013.

Based on Appaloosa Management's 13F filing for Q3 2013, filed 14 Nov 2013.